Showing results (291-300 of 317) with videos related to
Sort By:
Pageof 32
Journal of Neurochemistry|December 3, 1999
Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseJ Wiltfang, M Otto, H C Baxter, et al.Dementia and Geriatric Cognitive Disorders|April 16, 2004
Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in GermanyL Froelich, H-J Gertz, R Heun, et al.Molecular Psychiatry|February 7, 2007
Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patientsA W Henkel, P S Dittrich, T W Groemer, et al.The Journal of Biological Chemistry|August 30, 2001
Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cellsJ Wiltfang, H Esselmann, P Cupers, et al.Neuroreport|May 31, 1996
A null mutation allele in the CNTF gene and schizophrenic psychosesJ Thome, N Durany, A Harsányi, et al.Epilepsy & Behavior : E&B|February 2, 2016
Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in GermanyR D Nass, C Kurth, A Kull, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|June 30, 2009
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic studyM Jäger, M Schmauss, G Laux, et al.Neurology|May 20, 2009
A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCIF Jessen, O Gür, W Block, et al.Molecular Psychiatry|October 29, 2003
Erythropoietin: a candidate compound for neuroprotection in schizophreniaH Ehrenreich, D Degner, J Meller, et al.Journal of Neurochemistry|June 18, 2002
Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammationJ Wiltfang, H Esselmann, M Bibl, et al.Pageof 32